Intellectual Property India Publishes Patent Application for Composition For Eradicating Helicobacter Pylori Comprising Zastaprazan Or Pharmaceutically Acceptable Salt Thereof

MUMBAI, India, Aug. 17 -- Intellectual Property India has published a patent application (202617078773 A) filed by Jeil Pharmaceutical Co. , Ltd.; and Onconic Therapeutics Inc. on June 25, 2026, for Composition For Eradicating Helicobacter Pylori Comprising Zastaprazan Or Pharmaceutically Acceptable Salt Thereof.

Inventors include Kim, John; Cha, Hyun Ju; and Han, Sang Woo.

The application for the patent was published on August 14, 2026, under issue no. 33/2026.

Abstract: Disclosed is a composition for eradicating Helicobacter pylori, comprising zastaprazan or a pharmaceutically acceptable salt thereof.

Disclaimer: Curated by HT Syndication.